Carvedilol reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel

JL Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Gao Rl(Chinese Academy of Medical Sciences & Peking Union Medical College), Manman Zhai(Zhongyuan University of Technology), Youxue Liu(Chongqing Medical University), YH Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), WD Pei(Chinese Academy of Medical Sciences & Peking Union Medical College), YJ Yang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Perfusion
March 1, 2008
Cited by 11


Related Papers